Upcoming events
Great Small Talk Show
December 12th, 2024
Latest news
“I fell completely in love with the MedTech Industry”
In this interview with Sanna Severins, COO of Hy2Care®, we explore: Her career journey: From chemical engineering to MedTech, following her passion for healthcare innovation. Hy2Care’s technology: A revolutionary hydrogel implant designed for cartilage repair,...
Simac Masic Joins SBMC
Simac Masic, a subsidiary of Simac Techniek NV, has joined SBMC. What motivated this decision, and what does the company aim to gain and contribute within the consortium? We spoke with Has Verouden, Manager of Business Development, to gain insight into the company's...
Prof. Chris Arts: “I prefer projects that can be translated into patient care within ten years.”
Chris Arts is Professor of Translational Biomaterials at the research group for Orthopaedic Biomechanics at Eindhoven University and at Maastricht University Medical Centre, where he co-heads the Laboratory for Experimental Orthopaedics. He is also the project leader...
Latest news
“I fell completely in love with the MedTech Industry”
In this interview with Sanna Severins, COO of Hy2Care®, we explore: Her career journey: From chemical engineering to MedTech, following her passion for healthcare innovation. Hy2Care’s technology: A revolutionary hydrogel implant designed for cartilage repair,...
Simac Masic Joins SBMC
Simac Masic, a subsidiary of Simac Techniek NV, has joined SBMC. What motivated this decision, and what does the company aim to gain and contribute within the consortium? We spoke with Has Verouden, Manager of Business Development, to gain insight into the company's...
Prof. Chris Arts: “I prefer projects that can be translated into patient care within ten years.”
Chris Arts is Professor of Translational Biomaterials at the research group for Orthopaedic Biomechanics at Eindhoven University and at Maastricht University Medical Centre, where he co-heads the Laboratory for Experimental Orthopaedics. He is also the project leader...
SBMC Development Lab Welcomes Two New Devices for Rheological and Biomechanical Testing
SBMC is excited to announce the inauguration of two state-of-the-art devices in our development lab, pushing the boundaries of research and development capabilities. The first addition is the MCR 102e Rheometer from Anton Paar, equipped with various geometries,...
About SBMC
Smart Biomaterials Consortium (SBMC) facilitates researchers, entrepreneurs, leading companies and strategic investors working together on the development and clinical production of smart biomaterials that will radically change the future of healthcare.
SBMC enables product development through shared translational platforms that address the key bottlenecks in commercialization of regenerative medicine.
We offer high-quality facilities for industrialization of smart biomaterials and biodegradable implants used for regenerative medicine-based technologies.
Our team is comprised of dedicated scientists, process engineers, operators, quality staff, and other support functions. They bring years of extensive experience in regenerative medicine and smart biomaterial development and manufacturing. Excellent expertise of academic research institutes is involved and committed to support SBMC.
By partnering with leading research institutions and launching new ventures, SBMC accelerates the translation of promising technologies, processes, and therapies into life-changing health outcomes.
Looking for new business opportunities?
Contact Danielle Trappenburg, Business Developer
bd@